Johnson & Johnson vs Utilities Select Sector SPDR Fund — how do they compare? Johnson & Johnson trades at $261 (market cap $626.09B), while Utilities Select Sector SPDR Fund trades at $43.76. The key difference: Johnson & Johnson pays a 2.06% dividend while Utilities Select Sector SPDR Fund pays none, and Johnson & Johnson is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| JNJ | XLU | |
|---|---|---|
Market Cap | $626.09B | — |
Volume | 6,156,228 | — |
Sector | Health | — |
52-Week High | $267.24 | $47.73 |
52-Week Low | $172.78 | $41.31 |
Enterprise Value | $654.37B | — |
Dividend Yield | 2.06% | — |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
XLU, the Utilities Select Sector SPDR Fund, trades at $43.76, up 1.44% today but showing a bearish technical trend with 14 sell signals. The ETF benefits from AI-driven power demand, positioning utilities as growth plays amid easing rates. Recent news highlights unusual call option volume and a dividend scheduled for June 2026, reflecting defensive income appeal.
Outlook is mixed: AI power needs offer growth, but technical weakness and regulatory risks weigh. Investors gain exposure to stable dividends and infrastructure demand, yet face volatility from interest rates and grid capacity constraints. The stock's bearish signals suggest cautious entry points.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →